Identifying driver genes involving gene dysregulated expression, tissue-specific expression and gene-gene network

Area of Science:

• Genomics
• Bioinformatics
• Cancer Biology

Background:

• Cancer is a genomic alteration disease, with driver genes crucial for its development.
• Distinguishing driver mutations from passenger mutations remains a significant challenge in cancer research.
• Integrating biological networks with other data shows promise for driver gene identification.

Purpose of the Study:

• To develop a novel computational model for accurate identification of cancer driver genes.
• To improve the prediction performance of driver gene identification methods.

Main Methods:

• Proposed DyTidriver, a novel model integrating gene dysregulated expression, tissue-specific expression, and variation frequency.
• Utilized the human functional interaction network (FIN) as the underlying network structure.
• Applied the model to datasets from breast, prostate, and lung cancer patients.

Main Results:

• DyTidriver outperformed five existing methods in terms of F-score, Precision, and Recall.
• Identified driver genes were enriched in significant biological pathways.
• The method demonstrated capability in discovering previously unknown driver genes.

Conclusions:

• Driver genes significantly impact the expression of numerous downstream genes.
• Tissue-specific expression patterns are characteristic of functional gene modules.
• The DyTidriver model provides a robust approach for identifying cancer driver genes.